Mignone Roberto: insider trades.
Mignone Roberto reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($14.4M), across 2 companies.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 2
- Name as filed
- MIGNONE ROBERTO
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Guardant Health, Inc. (GH) | Director | 3 |
| Teva Pharmaceutical Industries Ltd (TEVA) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-21 | Guardant Health, Inc. | M | 264 | $0 | 10,274 | Form 4 |
| 2026-09-18 | Teva Pharmaceutical Industries Ltd | S | 367,600 | $39.06 | 0 | Form 4 |
| 2026-08-21 | Guardant Health, Inc. | M | 264 | $0 | 10,010 | Form 4 |
| 2026-07-21 | Guardant Health, Inc. | M | 264 | $0 | 9,746 | Form 4 |
Questions
What stock did Mignone Roberto buy or sell?
Mignone Roberto reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($14.4M), across 2 companies.
Is Mignone Roberto the same person as other filers with this name?
This page covers SEC CIK 1258394 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mignone-roberto-1258394.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.